NCT01132638 - Pantoprazole Magnesium 40 mg Versus Esomeprazole 40 mg in Patients With Erosive Gastroesophageal Reflux Disease | Biotech Hunter

Enrollment

713

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions

GERD

Interventions

DRUG

Magnesium Pantoprazole

1 capsule daily, 40 mg, orally, 30 minutes before breakfast

DRUG

Magnesium Esomeprazole

1 capsule daily, 40 mg, orally, 30 minutes before breakfast

Trial Locations (9)

Investigational site, Belo Horizonte/MG

Investigational site, Curitiba/PR

Investigational site, Goiânia/GO

Investigational site, Porto Alegre/RS

Investigational site, Ribeirão Preto/SP

Investigational site, Rio de Janeiro/RJ

Investigational site, Salvador/BA

Investigational site, Santo André/SP

Investigational site, São Paulo/SP